Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease.

[1]  Z. Tulassay,et al.  Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients , 2009, Inflammatory bowel diseases.

[2]  T. Chiba,et al.  High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease , 2009, Osteoporosis International.

[3]  W. Leslie,et al.  Vitamin D Status and Bone Density in Recently Diagnosed Inflammatory Bowel Disease: The Manitoba IBD Cohort Study , 2008, The American Journal of Gastroenterology.

[4]  R. D'Agostino,et al.  Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. , 2007, American journal of epidemiology.

[5]  K. Gedrich,et al.  Determinants and Correlates of Serum Undercarboxylated Osteocalcin , 2008, Annals of Nutrition and Metabolism.

[6]  M. Shiraki,et al.  Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women , 2008, Journal of Bone and Mineral Metabolism.

[7]  N. Maalouf,et al.  The Role of Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications , 2007 .

[8]  H. Takayanagi Novel signaling pathways and therapeutic targets in osteoclasts. , 2007, Advances in experimental medicine and biology.

[9]  O. Johnell,et al.  Latitude, socioeconomic prosperity, mobile phones and hip fracture risk , 2007, Osteoporosis International.

[10]  U. Gophna,et al.  Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[11]  S. Lanham-New,et al.  Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[12]  K. Horie-Inoue,et al.  Steroid and Xenobiotic Receptor SXR Mediates Vitamin K2-activated Transcription of Extracellular Matrix-related Genes and Collagen Accumulation in Osteoblastic Cells*♦ , 2006, Journal of Biological Chemistry.

[13]  Yusuke Ohsaki,et al.  Vitamin K Suppresses Lipopolysaccharide-Induced Inflammation in the Rat , 2006, Bioscience, biotechnology, and biochemistry.

[14]  M. Dougados,et al.  Bone loss in patients with inflammatory bowel disease: A prospective study , 1995, Osteoporosis International.

[15]  E. Vasiliauskas,et al.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density , 2004, Gut.

[16]  H. Bischoff-Ferrari,et al.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. , 2004, The American journal of medicine.

[17]  M. Shearer,et al.  Beyond Deficiency: , 2004, European journal of nutrition.

[18]  C. Cooper,et al.  Inflammatory bowel disease and the risk of fracture. , 2003, Gastroenterology.

[19]  C. Mathieu,et al.  Analogs of 1α,25‐dihydroxyvitamin D3 as pluripotent immunomodulators , 2003 .

[20]  J. Penninger,et al.  RANK-L and RANK: T cells, bone loss, and mammalian evolution. , 2002, Annual review of immunology.

[21]  H. DeLuca,et al.  Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  M. Takemitsu,et al.  Effect of vitamin K2 on lumbar vertebral bone: histomorphometric analyses in experimental osteoporotic rats , 2001, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[23]  A. Zittermann Effects of vitamin K on calcium and bone metabolism , 2001, Current opinion in clinical nutrition and metabolic care.

[24]  P. Meunier,et al.  Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? , 2001, The Lancet.

[25]  T. Hotokebuchi,et al.  Tumor necrosis factor-α cooperates with receptor activator of nuclear factor κB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture , 2001 .

[26]  L. Schurgers,et al.  Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? , 2001, Gut.

[27]  H Miura,et al.  Effect of Vitamin K2 on Three‐Dimensional Trabecular Microarchitecture in Ovariectomized Rats , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  K. Berkner The vitamin K-dependent carboxylase. , 2005, Annual review of nutrition.

[29]  Josef M. Penninger,et al.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.

[30]  B. Furie,et al.  Vitamin K-Dependent Biosynthesis of γ-Carboxyglutamic Acid , 1999 .

[31]  Z. Tulassay,et al.  Altered Bone Metabolism in Inflammatory Bowel Disease , 1998, American Journal of Gastroenterology.

[32]  I. Forgacs,et al.  Reduced bone density in patients with inflammatory bowel disease. , 1997, Gut.

[33]  M. Yamaguchi,et al.  Effect of vitamin K , 1996 .

[34]  B. Henderson,et al.  Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. , 1995, Cytokine.

[35]  M. Dougados,et al.  Metabolic bone assessment in patients with inflammatory bowel disease. , 1995, Gastroenterology.

[36]  M. Shiraki,et al.  Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. , 1993, Biochemical pharmacology.

[37]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[38]  D. Present,et al.  Preliminary report: cyclosporin in treatment of severe active ulcerative colitis , 1990, The Lancet.

[39]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.

[40]  J. Compston,et al.  Osteoporosis in patients with inflammatory bowel disease. , 1987, Gut.

[41]  T. Louie,et al.  Production of menaquinones by intestinal anaerobes. , 1984, The Journal of infectious diseases.

[42]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.